These studies by the Chamberlain laboratory provide a therapeutically attractive strategy for using patient-accessible fibroblasts cell population to enhance dystrophin expression in DMD; however, there remains a possibility that lentiviral vectors may induce an immune response when utilized at high doses, such as those that would be required for transduction in humans (Chamberlain, 2013). Here, DMD is linked to Duchenne muscular dystrophy.